OncoSil Medical Limited (ASX:OSL)
Australia · Delayed Price · Currency is AUD 0.4350
0.00 (0.00%)
Jun 3, 2026, 2:22 PM AEST
OncoSil Medical Market Cap
OncoSil Medical has a market cap or net worth of 13.35 million as of June 5, 2026. Its market cap has decreased by -27.53% in one year.
Market Cap
13.35M
Enterprise Value
10.54M
Revenue
3.72M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.44
Market Cap Chart
Since August 15, 2005, OncoSil Medical's market cap has increased from 7.29M to 13.35M, an increase of 83.05%. That is a compound annual growth rate of 2.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 3, 2026 | 13.35M | -27.13% |
| Dec 31, 2025 | 18.33M | -33.55% |
| Dec 31, 2024 | 27.58M | 55.21% |
| Dec 28, 2023 | 17.77M | -60.28% |
| Dec 30, 2022 | 44.74M | 25.48% |
| Dec 31, 2021 | 35.65M | -63.58% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nova Eye Medical | 32.76M |
| Micro-X | 28.44M |
| CleanSpace Holdings | 28.41M |
| Control Bionics | 24.31M |
| CurveBeam AI | 21.98M |
| ImpediMed | 18.71M |
| CONNEQT Health | 18.02M |
| Memphasys | 17.08M |